Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: May 2010
-
"Biotech/Pharma" Top 47" By Donald Zuhn — The Intellectual Property Owners Association (IPO) released its 27th annual list of the top 300 organizations receiving U.S. patents. Patent Docs Readers may recall that the U.S. Patent & Trademark Office stopped releasing its annual list of top patent recipients in 2006 in order to "discourag[e] any…
-
By James DeGiulio — Earlier this year, GlaxoSmithKline announced an "open innovation" strategy to help deliver new and better medicines for diseases disproportionately affecting people living in the world's poorest countries. Making good on that promise, GSK has teamed up with the European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM), and…
-
By James DeGiulio — Despite the global economic outlook improving considerably over the last year, an industry survey by international intellectual property group Marks & Clerk suggests that the biotech and pharmaceutical industry may be entering a critical phase in terms of drug innovation and development. The research identifies a number of industry-specific problems,…
-
By Sarah Fendrick — On May 17, the U.S. Patent and Trademark Office (USPTO) announced in a press release it would be expanding the "Project Exchange" program to all applicants. The program enables an applicant with multiple pending applications, filed prior to the inception of the program, to receive expedited review of one application…
-
By Jori Fuller — As some practitioners and applicants may have noticed, the U.S. Patent and Trademark Office has begun sending out decisions on Requests for Recalculation of PTA in view of the Federal Circuit's decision in Wyeth v. Kappos. These decisions include a newly calculated PTA in view of Wyeth, and also…
-
By Donald Zuhn — Last month, in Vanderbilt Univ v. ICOS Corp., the Federal Circuit affirmed a decision of the District Court for the District of Delaware finding that Plaintiff-Appellant Vanderbilt University had failed to prove that Vanderbilt scientists Drs. Jackie Corbin, Sharron Francis, and Sekhar Konjeti were joint inventors of U.S. Patent Nos.…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Medicis Pharmaceutical Corp. v. Nycomed US Inc. et al.1:10-cv-00419; filed May 19, 2010 in the District Court of Delaware • Plaintiff: Medicis Pharmaceutical Corp.• Defendants: Nycomed US Inc.; Nycomed GmbH Medicis Pharmaceutical Corp. v.…
-
May 24-25, 2010 – Hatch-Waxman Boot Camp*** (American Conference Institute) – San Diego, CA May 24-26, 2010 – Pharmaceutical & Biotech Patent Litigation Strategies*** (Pharma IQ) – London, England May 25, 2010 – "The Gene Uncertainty: What to Do After Myriad" (Intellectual Property Owners Association) – 2:00 PM (EST) May 25, 2010 – Corporate Intellectual…
-
The Chisum Patent Academy will offer its second annual Intensive Patent Law Training Workshop on on July 29-31, 2010 in Seattle, WA. The workshop will focus on substantive patent law (patentability and enforcement) through analysis of critical Federal Circuit and Supreme Court decisions. The 2009 syllabus can be viewed here; new material for the 2010…
-
By James DeGiulio — Covidien's Patent for Restoril Found Obvious Covidien PLC suffered a setback in its infringement suit with URL Pharma Inc. after the claims of its patent for sleep aid Restoril were found obvious. In March 2007, Tyco Healthcare Group LP, now Covidien, brought suit against Pharmaceutical Holdings Corp., and its subsidiary…
Patent Docs 